DSM-Firmenich AG
AEX:DSFIR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
85.51
123.65
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DSFIR stock under the Base Case scenario is 103.75 EUR. Compared to the current market price of 107.25 EUR, DSM-Firmenich AG is Overvalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
DSM-Firmenich AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DSFIR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
DSM-Firmenich AG is a global leader in the nutrition, health, and beauty sectors, born from the merger of Dutch multinational DSM and Swiss flavor and fragrance company Firmenich. This innovative company specializes in creating sustainable solutions, leveraging science and technology to enhance the quality of life across a diverse range of industries, including food, beverages, personal care, and pharmaceuticals. With a robust portfolio of products aimed at enriching human and environmental health, DSM-Firmenich aims to meet the growing consumer demand for healthier, more sustainable options. Their commitment to sustainability positions them favorably within the markets they serve, as consum...
DSM-Firmenich AG is a global leader in the nutrition, health, and beauty sectors, born from the merger of Dutch multinational DSM and Swiss flavor and fragrance company Firmenich. This innovative company specializes in creating sustainable solutions, leveraging science and technology to enhance the quality of life across a diverse range of industries, including food, beverages, personal care, and pharmaceuticals. With a robust portfolio of products aimed at enriching human and environmental health, DSM-Firmenich aims to meet the growing consumer demand for healthier, more sustainable options. Their commitment to sustainability positions them favorably within the markets they serve, as consumers increasingly seek brands that prioritize their health and the planet.
For investors, DSM-Firmenich stands out not just for its impressive offerings but also for its strategic vision that emphasizes long-term growth and resilience. The company's strong financial track record, combined with its focus on innovation and operational efficiency, underpins its potential to capitalize on emerging trends within the wellness and sustainability industries. As global populations expand and consumer preferences shift towards health-conscious choices, DSM-Firmenich is well-placed to leverage its expertise and comprehensive understanding of the market. By investing in this forward-thinking enterprise, investors can participate in a company that is not only poised for financial success but also dedicated to making a positive impact on society and the environment.
DSM-Firmenich AG is a global leader in health, nutrition, and sustainable living, resulting from the merger of Royal DSM and Firmenich. The company operates in several core business segments, which are generally categorized as follows:
-
Nutrition:
- This segment includes dietary supplements, functional foods, and ingredients that promote health and wellness. DSM-Firmenich offers a range of vitamins, minerals, and other essential nutrients that cater to the food and beverage industry, as well as healthcare products aimed at improving well-being.
-
Health:
- This division focuses on pharmaceutical ingredients and solutions, including active pharmaceutical ingredients (APIs), nutritional healthcare products, and regulatory services. The aim is to enhance health outcomes through innovative formulation and delivery methods.
-
Food & Beverage:
- This segment emphasizes flavor and fragrance solutions that improve the sensory experience of food and beverages. Through Firmenich's expertise, the company provides taste enhancers, natural ingredients, and aroma solutions that meet consumer demand for healthier and more sustainable options.
-
Personal Care & Home:
- DSM-Firmenich in this segment focuses on products related to personal care and household goods. This includes the development of fragrances, active ingredients, and formulations for cosmetics, skincare, and cleaning products.
-
Bio-Based and Sustainable Solutions:
- The company is also committed to sustainability, developing bio-based alternatives and focusing on circular economy principles. This segment includes innovations that reduce environmental impact and enhance the sustainability of products across industries.
-
Innovation and Development:
- A part of all segments, this involves investing in R&D to develop new technologies and solutions that respond to shifting market demands and consumer trends, particularly in the areas of health and sustainability.
These segments reflect DSM-Firmenich's commitment to innovation, sustainability, and health, positioning the company to meet the evolving demands of consumers and industries worldwide.
DSM-Firmenich AG, formed from the merger of DSM and Firmenich, holds several unique competitive advantages over its rivals in the market, particularly within the fields of nutrition, health, and biosciences. Here are some key advantages:
-
Diversified Product Portfolio: DSM-Firmenich offers a broad range of products including vitamins, enzymes, and bio-based solutions, positioning itself well across various sectors like food, beverages, personal care, and health. This diversification reduces dependency on any single market segment.
-
Strong R&D Capabilities: The company invests significantly in research and development, allowing it to innovate continuously and develop cutting-edge products that meet changing consumer demands. This commitment to innovation helps in creating unique solutions that rival companies may not readily replicate.
-
Sustainability Commitments: DSM-Firmenich emphasizes sustainable practices and bio-based products, which resonate well with environmentally conscious consumers and businesses. Their focus on sustainability can provide a competitive edge as markets increasingly demand greener alternatives.
-
Global Reach and Scale: With a significant global presence, DSM-Firmenich can leverage economies of scale in production and supply chain management. This global footprint allows for better market penetration and responsiveness to local needs.
-
Strong Brand Reputation and Trust: The legacy brands of DSM and Firmenich carry significant trust and credibility in the market. A strong brand reputation can facilitate customer loyalty and make it easier to enter new markets.
-
Collaborative Partnerships: The company often engages in collaborations and partnerships with other firms, research institutions, and sustainability initiatives. These alliances can foster innovation, reduce costs, and enhance market reach.
-
Focus on Health and Nutrition Trends: With heightened consumer awareness surrounding health and nutrition, DSM-Firmenich is well-positioned to capitalize on these trends, providing products that align with consumer demand for health-focused solutions.
-
Vertical Integration: By controlling various aspects of its supply chain from raw materials to finished products, DSM-Firmenich can ensure quality, reduce costs, and improve operational efficiencies, giving it a competitive edge over rivals.
By leveraging these advantages, DSM-Firmenich AG can maintain and enhance its competitive position in the market while addressing the evolving needs of consumers and businesses.
DSM-Firmenich AG, a leading company in health, nutrition, and biosciences, faces several risks and challenges in the near future. Here are some key considerations:
-
Market Volatility: Changes in consumer preferences, shifts toward plant-based products, and health trends can impact demand. Economic downturns or recessions could further affect consumer spending on premium products.
-
Supply Chain Disruptions: The global supply chain remains vulnerable to disruptions from geopolitical tensions, pandemics, or natural disasters. This can lead to increased costs and delays in product delivery.
-
Regulatory Compliance: As a company operating in health and nutrition, DSM-Firmenich must navigate a complex web of regulations and compliance standards across different regions. Changes in regulations can increase operational complexity and costs.
-
Sustainability Pressures: There is growing pressure from consumers and regulators for companies to adopt sustainable practices. DSM-Firmenich has set ambitious sustainability goals, and failing to meet them could impact their reputation and market position.
-
Technological Advances: The rapid pace of technological innovation in biotechnology and nutrition means that DSM-Firmenich must consistently innovate. Failure to keep up with advancements could lead to loss of market competitiveness.
-
Competition: The health and nutrition market is highly competitive, with both established players and new entrants. DSM-Firmenich must continuously differentiate its products to maintain its market share.
-
Financial Risks: Fluctuations in commodity prices, currency exchange rates, and interest rates can affect profitability. The company must manage these financial risks effectively.
-
Integration Challenges: Following the merger of DSM and Firmenich, integrating operations, cultures, and systems can pose challenges. Successful integration is essential for capturing synergies and driving growth.
-
Consumer Awareness and Safety: Any incidents related to product safety or negative publicity can affect consumer confidence and brand loyalty. Maintaining high standards of quality and safety is crucial.
-
Geopolitical Risks: Political instability, trade wars, and changes in trade agreements can affect operations and profitability, especially in key markets.
By addressing these risks and challenges proactively, DSM-Firmenich AG can position itself to navigate the complexities of the health and nutrition landscape and continue its growth trajectory.
Revenue & Expenses Breakdown
DSM-Firmenich AG
Balance Sheet Decomposition
DSM-Firmenich AG
Current Assets | 10.3B |
Cash & Short-Term Investments | 3.4B |
Receivables | 3.1B |
Other Current Assets | 3.9B |
Non-Current Assets | 24.8B |
Long-Term Investments | 965m |
PP&E | 5.3B |
Intangibles | 18.4B |
Other Non-Current Assets | 135m |
Current Liabilities | 4.8B |
Accounts Payable | 2.1B |
Other Current Liabilities | 2.7B |
Non-Current Liabilities | 7.3B |
Long-Term Debt | 4.1B |
Other Non-Current Liabilities | 3.2B |
Earnings Waterfall
DSM-Firmenich AG
Revenue
|
10.6B
EUR
|
Cost of Revenue
|
-8B
EUR
|
Gross Profit
|
2.6B
EUR
|
Operating Expenses
|
-3.1B
EUR
|
Operating Income
|
-442m
EUR
|
Other Expenses
|
2.6B
EUR
|
Net Income
|
2.1B
EUR
|
Free Cash Flow Analysis
DSM-Firmenich AG
EUR | |
Free Cash Flow | EUR |
DSFIR Profitability Score
Profitability Due Diligence
DSM-Firmenich AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
DSM-Firmenich AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
DSFIR Solvency Score
Solvency Due Diligence
DSM-Firmenich AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
DSM-Firmenich AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DSFIR Price Targets Summary
DSM-Firmenich AG
According to Wall Street analysts, the average 1-year price target for DSFIR is 133.81 EUR with a low forecast of 116.15 EUR and a high forecast of 153.3 EUR.
Dividends
Current shareholder yield for DSFIR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
Contact
IPO
Employees
Officers
The intrinsic value of one DSFIR stock under the Base Case scenario is 103.75 EUR.
Compared to the current market price of 107.25 EUR, DSM-Firmenich AG is Overvalued by 3%.